Kimi Iguchi
Director of Finance/CFO bij SAGE THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Momenteel bekleedt Kimi E. Iguchi de functie van Chief Financial Officer & Treasurer bij SAGE Therapeutics, Inc. Mevrouw Iguchi zetelt ook in de raad van bestuur van Disarm Therapeutics, Inc. Voordien was zij Vice President-Finance van Cyberkinetics Neurotechnology Systems, Inc., Chief Operating Officer-North America Region bij Santhera Pharmaceuticals Holding AG, Senior Manager-External Reporting bij Biogen, Inc. en Finance Manager bij Biogen MA, Inc. (een dochteronderneming van Biogen, Inc.), Senior Director-Finance, Reporting & Analysis bij Millennium Pharmaceuticals, Inc. en Manager-Business Assurance bij PricewaterhouseCoopers LLP. Mevrouw Iguchi behaalde een bachelorgraad aan de Drew University en een MBA aan de Northeastern University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
SAGE THERAPEUTICS, INC.
0.14% | 13-02-2024 | 81 679 ( 0.14% ) | 2 M $ | 31-03-2024 |
Actieve functies van Kimi Iguchi
Bedrijven | Functie | Begin |
---|---|---|
SAGE THERAPEUTICS, INC. | Director of Finance/CFO | 01-03-2013 |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Director/Board Member | 25-10-2018 |
Eerdere bekende functies van Kimi Iguchi
Bedrijven | Functie | Einde |
---|---|---|
SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 01-09-2011 |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Director of Finance/CFO | 31-05-2007 |
BIOGEN INC. | Corporate Officer/Principal | 01-01-1998 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01-01-1995 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Director of Finance/CFO | - |
Opleiding van Kimi Iguchi
Drew University | Undergraduate Degree |
Northeastern University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
BIOGEN INC. | Health Technology |
SAGE THERAPEUTICS, INC. | Health Technology |
SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Health Technology |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Health Technology |